Clinical Trial Update: Redirected Auto T Cells for Advanced Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for redirected autologous T cells in advanced multiple myeloma; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2019-01-03